openPR Logo
Press release

Anti-Obesity Drugs Market, Business Will Grow in 2027, Prominent Top Players: Arena Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc

03-25-2020 01:38 PM CET | Health & Medicine

Press release from: Allied Market Research

Anti-Obesity Drugs Market

Anti-Obesity Drugs Market

Anti-Obesity Drugs Market 2020-2027: According to a new report published by Allied Market Research, titled, "Global Anti-Obesity Drugs Market by Drug Class (Peripherally Acting Anti-obesity Drugs, and Centrally Acting Anti-obesity Drugs), Medication (Monotherapies and Polytherapies), and Type (Prescription Drugs and OTC Drugs) - Opportunity Analysis and Industry Forecast, 2020-2027"

Anti-obesity drugs are pharmacological agents that are used to lose cholesterol and reduce the body weight. These drugs generally show their action by altering the fundamental functioning of the normal body by utilization of calories or by altering the appetite.

Download Report Sample (320 Pages PDF with Insights) https://www.alliedmarketresearch.com/request-sample/4170

The global market size of Anti-Obesity Drugs Market is $XX million in 2019 with XX CAGR, and it is expected to reach $XX million by the end of 2027 with a CAGR of XX% from 2020 to 2027.

The Major Key Players Are:

Arena Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Alizyme plc, Boehringer Ingelheim GmbH, Novo Nordisk A/S, Pfizer Inc, Shionogi Inc., Merck & Co., Inc., and Norgine B.V.

Key Benefits:

o The study provides an in-depth analysis of the market with current trends and future estimations to elucidate imminent investment pockets.
o It offers a quantitative analysis from 2018 to 2027, which is expected to enable stakeholders to capitalize on prevailing market opportunities.
o Extensive analysis by product helps understand various types of drugs used to treat obesity.
o Comprehensive analysis of all geographical regions has been provided, which helps determine prevailing opportunities.
o Key players have been profiled and their strategies thoroughly analyzed, which helps understand the competitive outlook of the global market.

Inquire More About This Report Before Making Decision To Purchase: https://www.alliedmarketresearch.com/purchase-enquiry/4170

Global Anti-obesity Drugs Market Key Segments:

By Drug Class

o Peripherally Acting Anti-obesity Drugs
o Centrally Acting Anti-obesity Drugs

By Medication

o Monotherapies
o Polytherapies

By Type

o Prescription Drugs
o OTC drugs

By Region

o North America
o U.S.
o Canada
o Mexico
o Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe
o Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o Rest of Asia-Pacific
o LAMEA
o Brazil
o South Africa
o Saudi Arabia
o Rest of LAMEA

Access Full Report @ https://www.alliedmarketresearch.com/anti-obesity-drugs-market

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us:

Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anti-Obesity Drugs Market, Business Will Grow in 2027, Prominent Top Players: Arena Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc here

News-ID: 1983943 • Views: 460

More Releases from Allied Market Research

Tow Truck Market Top Manufacturers, Product Types, Sales and Demand 2020-2027
Tow truck also known as a recovery vehicle is used to move improperly parked, damaged, and impounded motor vehicles from one place to another. Furthermore, brackets are the devices used to lift the vehicle which avoids damaging the front panel of the vehicle. Brackets are installed around the wheels of the vehicle and then are secured in place with steel pins. Tow trucks are designed to safely and quickly transport
Microscope Market 2020-2027: Emerging Trends, Market Share, Top Impacting Factor …
Allied Market Research published an exclusive report, titled, “Microscope Market By Type (Scanning Electron Microscope, Transmission Electron Microscope, Focused Ion Beam, and Others) and End Use (Semiconductor & Microelectronics, Healthcare, General Manufacturing, Food Processing, Construction, and Other): Global Opportunity Analysis and Industry Forecast, 2020–2027”. The microscope market report offers an in-depth analysis of every crucial factor that affects the market growth including recent market developments, key market players, and decisive trends.
Epigenetics Market Share Analysis, Advancement and Precise Outlook – 2023
According to the report, the global epigenetics market was valued at $630 million in 2017 and is expected to reach $1,321 million by 2023, registering a CAGR of 13.1% during the forecast period. Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/846 Epigenetics is an area of developmental biology that involves the study of cellular and physiological trait variations initiated by external or ecological aspects. This external stimulus swipe genes on and off and affect
Postpartum Hemorrhage (PPH) Devices Market Top-Companies, Future-Growth, Regiona …
The factors that are expected to drive the growth of the PPH market are: increasing incidence of pregnancy related complications, such as multiple pregnancies, inverted uterus, and large baby size; increasing risk factors which cause PPH, such as uterine atony, trauma, retained placenta, and bleeding disorders; and technological advancements in the recently approved devices. However, the lack of trained professionals and healthcare services in developing countries hamper the market growth. Post-partum

All 5 Releases


More Releases for Drug

Biologics Drug Discovery Market
2019-2025 Biologics Drug Discovery Market Report with Depth Analysis The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization. The report presents a comprehensive overview, market size, shares, and growth opportunities of Biologics Drug Discovery market by product type, application, key manufacturers and key regions. Request For Free report Sample -https://www.reportsmonitor.com/request_sample/306320 Scope of the Report: Furthermore, Biologics Drug Discovery Market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers or
Opioid Antagonist Drug Market
The global market has been prognosticated to earn demand from popular types of products such as external use, oral and applications such as household and hospital. The Company has made available another publication in its Healthcare archive of market intelligence reports, which is titled “Global Opioid Antagonist Drug Market Research Report 2018.” While the threat of substitutes and technological risks could have an unfavorable impact on the global market, potential
Drug and cosmetics
Drug and Cosmetics Conferences regards each one of the individuals to go to the On “Drug and Cosmetics” amidst October 17-October 18, 2018 in Toronto, Canada which melds brief keynote presentations, speaker talks, Exhibition, Symposia, Workshops. Drug and Cosmetics Congress is one of the meetings and conferences which will be visited by all the prestigious cosmetologists, Scientists, fiery inspectors, postgraduates, affiliations, business meanders under a solitary rooftop. DRug and cosmetics BLESSY MATHEW Program
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
US Alzheimer Drug Pipeline Analysis
In US, the Alzheimer's disease is the 6th leading cause of death overall and among those aged 65 and above, it is the 5th leading cause of death. While the deaths from major diseases, like heart disease have decreased, the death due to Alzheimer's have increased by more than 60% between 2000 and 2012. The total number of patients having Alzheimer’s disease was 5.4 million in 2012. Out of this,